Trials / Completed
CompletedNCT00538109
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- King Faisal Specialist Hospital & Research Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients with Imatinib (Glivec®/Gleevec®\_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glivec®/Gleevec® | Chemotherapy |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2007-10-02
- Last updated
- 2015-12-16
Source: ClinicalTrials.gov record NCT00538109. Inclusion in this directory is not an endorsement.